Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8-Reference-Cited by-同舟云学术

Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8

Published:2017-08 Issue:8 Volume:19 Page:463-470
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Harris Cynthia¹,Forst Thomas²,Heise Tim²,Plum-Mörschel Leona³,Watkins Elaine⁴⁵,Zhang Qianyi¹,Fan Ludi¹,Garhyan Parag¹,Porksen Niels¹

Affiliation:

1. Eli Lilly and Company, Indianapolis, Indiana, USA.

2. Profil, Neuss, Germany.

3. Profil, Mainz, Germany.

4. Profil Institute for Clinical Research, Chula Vista, California, USA.

5. Pharmaceutical Product Development, Inc., Wilmington, North Carolina, USA.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.liebertpub.com/doi/pdf/10.1089/dia.2016.0414

Reference25 articles.

1. Adherence to insulin treatment in insulin-naïve type 2 diabetic patients initiated on different insulin regimens

2. National Estimates of Insulin-Related Hypoglycemia and Errors Leading to Emergency Department Visits and Hospitalizations

3. Defining and Reporting Hypoglycemia in Diabetes

4. Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society

5. Glucose Concentrations of Less Than 3.0 mmol/L (54 mg/dL) Should Be Reported in Clinical Trials: A Joint Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insulin Therapy for the Management of Diabetes Mellitus: A Narrative Review of Innovative Treatment Strategies;Diabetes Therapy;2023-09-22

2. Reduced hypoglycaemia using liver‐targeted insulin in individuals with type 1 diabetes;Diabetes, Obesity and Metabolism;2022-05-25

3. A Euglycemic Glucose Clamp Study to Evaluate the Bioavailability of LY2963016 Relative to Insulin Glargine in Healthy Chinese Subjects;Clinical Pharmacology in Drug Development;2021-08-19

4. Peripherally delivered hepatopreferential insulin analog insulin‐406 mimics the hypoglycaemia‐sparing effect of portal vein human insulin infusion in dogs;Diabetes, Obesity and Metabolism;2019-07-08